, Tracking Stock Market Picks
Enter Symbol:
Concert Pharmaceuticals Inc. (CNCE) [hlAlert]

up 11.99 %

Concert Pharmaceuticals Inc. (CNCE) rated Buy with price target $32 by ROTH Capital

Posted on: Tuesday,  Sep 22, 2015  1:25 PM ET by Roth Capital

Roth Capital rated Buy Concert Pharmaceuticals Inc. (NASDAQ: CNCE) on 09/22/2015. Previously Roth Capital rated Buy Concert Pharmaceuticals Inc. (NASDAQ: CNCE) on
03/19/2014., when the stock price was $13.92. Since then, Concert Pharmaceuticals Inc. has gained 12.00% as of 09/22/2015's recent price of $15.59.
If you would have followed the previous Roth Capital's recommendation on CNCE, you would have gained 11.99% of your investment in 552 days.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/22/2015 1:25 PM Buy
as of 8/27/2015
1 Week down  -7.36 %
1 Month up  0.45 %
3 Months up  9.94 %
1 YTD up  23.92 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2014 12:25 PM Buy
12.58 21.00
3/19/2014 9:25 AM Buy
13.92 28.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy